Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
Robert G Maki, David R D'Adamo, Mary L Keohan, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
Radiology
|
September 3, 2024
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer
Hannah Williams, Dana M Omer, Hannah M Thompson, et al.
JAMA Network Open
|
January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial
Hannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II study of sorafenib in patients with metastatic or recurrent sarcomas
Robert G Maki, David R D'Adamo, Mary L Keohan, et al.
JAMA Oncology
|
January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical Trial
Ciara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma
Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting, et al.
Journal for Immunotherapy of Cancer
|
May 4, 2026
Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma
Evan Rosenbaum, Kenneth Seier, Rodrigo Gularte-Mérida, et al.
Radiology
|
September 3, 2024
MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer
Hannah Williams, Dana M Omer, Hannah M Thompson, et al.
JAMA Network Open
|
January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial
Hannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors
Ping Chi, Li-Xuan Qin, Niedzica Camacho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Sujana Movva, Kenneth Seier, Viswatej Avutu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 10, 2022
A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
Evan Rosenbaum, Rashmi Chugh, Christopher W Ryan, et al.
Journal for Immunotherapy of Cancer
|
June 13, 2025
Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma
Sujana Movva, Kenneth Seier, Martina Bradic, et al.
Page
of 14